Skip to menu Skip to content Skip to footer

2007

Journal Article

Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury

Gobe, Glenda C. and Johnson, David W. (2007). Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury. The International Journal of Biochemistry & Cell Biology, 39 (9), 1551-1561. doi: 10.1016/j.biocel.2007.04.025

Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury

2007

Journal Article

Prevention of progression of kidney disease: CARI guidelines

Johnson, David W. (2007). Prevention of progression of kidney disease: CARI guidelines. Australian Family Physician, 36 (5), 353-353.

Prevention of progression of kidney disease: CARI guidelines

2007

Journal Article

How to treat: Resistant hypertension

Johnson, David W. (2007). How to treat: Resistant hypertension. Australian Doctor, 20, 27-28, 30-32, 34.

How to treat: Resistant hypertension

2007

Journal Article

Resistant hypertension

Johnson D.W. (2007). Resistant hypertension. Australian Doctor (20/APR)

Resistant hypertension

2007

Journal Article

Drug dosing adjustment in people with reduced GFR

Mathew, Timothy, Jones, Graham and Johnson, David (2007). Drug dosing adjustment in people with reduced GFR. Australian Prescriber, 30 (2), 34-34.

Drug dosing adjustment in people with reduced GFR

2007

Journal Article

Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)

Qi, Weier, Johnson, David W., Vesey, David A., Pollock, Carol A. and Chen, Xinming (2007). Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research). Nephrology, 12 (2), 155-159. doi: 10.1111/j.1440-1797.2007.00779.x

Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)

2007

Journal Article

Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3

Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3. BJU International, 99 (2), 454-460. doi: 10.1111/j.1464-410X.2007.06571.x

Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3

2007

Journal Article

Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney

Vesey, David A., Hooper, John D., Gobe, Glenda C. and Johnson, David W. (2007). Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney. Nephrology, 12 (1), 36-43. doi: 10.1111/j.1440-1797.2006.00746.x

Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney

2007

Journal Article

Modification of cardiovascular risk in hemodialysis patients: an evidence-based review

Johnson, David W., Craven, Ann-Maree and Isbel, Nicole Maree (2007). Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodialysis International, 11 (1), 1-14. doi: 10.1111/j.1542-4758.2007.00146.x

Modification of cardiovascular risk in hemodialysis patients: an evidence-based review

2007

Conference Publication

Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injury

Yamada, M., Burke, C., Colditz, P., Johnson, D. W. and Gobe, G. C. (2007). Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injury. Australian Society of Medical Research Annual Scientific Meeting, Blue Mountains, NSW, November, 2007.

Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injury

2007

Book Chapter

Hypokalaemia and Metabolic Alkalosis

Johnson, David W. (2007). Hypokalaemia and Metabolic Alkalosis. Clinical Cases in Kidney Disease. (pp. 1-1) edited by D.C.H. Harris. North Ryde, NSW Australia: McGraw-Hill Australia.

Hypokalaemia and Metabolic Alkalosis

2007

Conference Publication

MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure

Liu, H., McTaggart S., Johnson, D. W. and Gobe, G. C. (2007). MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure. World Congress of Nephrology 2007 (WCN2007), Rio de Janeiro, Brazil, 21-25 April 2007. International Society of Nephrology.

MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure

2007

Conference Publication

Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell Publishing.

Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population

2007

Conference Publication

Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period

Staatz, Christine, Wong, Jenny, Taylor, Paul, Johnson, David and Tett, Susan (2007). Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period. 10th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Nice, France, 9-14 September, 2007. New York: Lippincott-Raven. doi: 10.1097/FTD.0b013e31813797e8

Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period

2007

Conference Publication

TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers

Rajandram, R., Pat, B. K., Li, J., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2007). TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers. National Cancer Research Institute Conference, Birmingham, England, 2-5 October, 2007.

TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers

2007

Conference Publication

Follow-up of 15 years of live donors in a large Australian renal transplant unit

Kaisar, M. O., Isbel, N., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Campbell, S. (2007). Follow-up of 15 years of live donors in a large Australian renal transplant unit. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Follow-up of 15 years of live donors in a large Australian renal transplant unit

2007

Conference Publication

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

2007

Journal Article

Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns

Gobe, Glenda C., Endre, Zoltan H. and Johnson, David W. (2007). Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns. Drug Discovery Today: Therapeutic Strategies, 4 (1), 79-84. doi: 10.1016/j.ddstr.2007.07.001

Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns

2007

Conference Publication

Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes

Ghali, J., McDonald, S., Bannister, K. M., ANZDATA Peritonitis Working Group and Johnson, D. W. (2007). Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes. Nephrology 2007: 43rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Gold Coast, QLD, Australia, 8-12 September 2007. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2007.00847.x

Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes

2007

Conference Publication

Molecular and cellular changes associated with age-related chronic kidney disease

Percy, C., Brown, L., Power, D., Johnson, D. W. and Gobe, G. C. (2007). Molecular and cellular changes associated with age-related chronic kidney disease. International Society of Nephrology's World Congress of Nephrology 2007, Rio de Janeiro, Brazil, 21-25 April 2007.

Molecular and cellular changes associated with age-related chronic kidney disease